| Title : An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials - Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| Author(s) : Ligueros-Saylan M , Foley JE , Schweizer A , Couturier A , Kothny W |
| Ref : Diabetes Obes Metab , 12 :495 , 2010 |
| Abstract : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| ESTHER : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| PubMedSearch : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| PubMedID: 20518805 |
| Title : Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus - Kikuchi_2010_Diabetes.Res.Clin.Pract_89_216 |
| Author(s) : Kikuchi M , Haneda M , Koya D , Tobe K , Onishi Y , Couturier A , Mimori N , Inaba Y , Goodman M |
| Ref : Diabetes Res Clin Pract , 89 :216 , 2010 |
| Abstract : Kikuchi_2010_Diabetes.Res.Clin.Pract_89_216 |
| ESTHER : Kikuchi_2010_Diabetes.Res.Clin.Pract_89_216 |
| PubMedSearch : Kikuchi_2010_Diabetes.Res.Clin.Pract_89_216 |
| PubMedID: 20537746 |
| Title : Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea - Garber_2008_Diabetes.Obes.Metab_10_1047 |
| Author(s) : Garber AJ , Foley JE , Banerji MA , Ebeling P , Gudbjornsdottir S , Camisasca RP , Couturier A , Baron MA |
| Ref : Diabetes Obes Metab , 10 :1047 , 2008 |
| Abstract : Garber_2008_Diabetes.Obes.Metab_10_1047 |
| ESTHER : Garber_2008_Diabetes.Obes.Metab_10_1047 |
| PubMedSearch : Garber_2008_Diabetes.Obes.Metab_10_1047 |
| PubMedID: 18284434 |